Chinese scientists have made significant advancements in cancer treatment by developing a groundbreaking therapy that modifies tumors to resemble “pork,” thereby stimulating the body’s immune system to recognise and attack them. This innovative approach has been reported by the South China Morning Post and has garnered considerable attention.
Researchers engineered tumors to mimic pig tissue, triggering the immune system’s response mechanisms typically associated with organ transplant rejection. The study, published in the journal Cell on January 18, employs a genetically modified virus to disguise cancer cells as pig tissue, resulting in a hyperacute immune rejection that specifically targets tumors while leaving healthy cells unharmed.
Early clinical trials have yielded impressive results, with 90% of patients suffering from advanced, treatment-resistant cancers experiencing either halted tumor growth or shrinkage. Notably, one cervical cancer patient has been declared clinically cured, showcasing the therapy’s potential.
This breakthrough offers renewed hope to patients whose cancers have been unresponsive to conventional treatments, paving the way for a promising new direction in oncology. The research is led by Professor Zhao Yongxiang, director of the State Key Laboratory of Targeting Oncology at Guangxi Medical University, and has rapidly gained traction on Chinese social media platforms.
As the treatment progresses through further trials, it stands to potentially revolutionise the standard of care for cancer patients, particularly those facing limited options.
Source : AA
